Physician

Samuel M. Ortiz, M.D.

According to 2025 Medicare claims, Samuel Ortiz, M.D. (NPI: 1740286681) practices internal medicine in the Wenatchee-East Wenatchee, WA market, with the plurality of this provider's patient population coming from Douglas, WA. This provider's primary affiliated billing organization is CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (NPI: 1881642239; TIN: 910171250) and primary practice location at 98801-3201. Ortiz is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Ortiz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 411 traditional Medicare patients, billed 2,660 HCPCS/CPT codes, and received $132,205 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,024 prescription claims across 559 beneficiaries totaling $648,253 in drug costs, led by Eliquis (Apixaban). DME data shows 180 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $402,475 to $648,253. For DME billing, reported payments rose steadily, from $16,853 to $43,001.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	526	2,330	$111,715
2016	507	2,252	$107,365
2017	523	2,150	$104,620
2018	492	2,400	$114,941
2019	474	2,318	$115,101
2020	436	2,060	$132,969
2021	447	1,762	$119,338
2022	433	1,822	$130,209
2023	436	1,768	$122,291
2024	411	2,660	$132,205

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	618	8,424	$402,475
2016	678	8,376	$436,298
2017	710	8,346	$440,482
2018	533	8,191	$549,348
2019	481	8,479	$571,741
2020	475	8,673	$552,103
2021	514	8,517	$578,397
2022	529	8,252	$637,305
2023	581	8,037	$700,566
2024	559	9,024	$648,253

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	110	488	$15,729
2016	147	446	$10,170
2017	104	436	$9,122
2018	107	482	$7,898
2019	101	540	$9,836
2020	92	576	$17,109
2021	74	527	$28,450
2022	65	394	$22,982
2023	42	310	$21,020
2024	38	180	$24,374

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	224	224	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	105	136	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	356	832	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	142	186	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	341	872	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	151	8,715	$165,679
Trulicity	Dulaglutide	112	4,454	$145,971
Xarelto	Rivaroxaban	27	1,890	$34,589
Jardiance	Empagliflozin	47	1,956	$33,724
Entresto	Sacubitril/Valsartan	28	1,140	$26,301

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	43	$18,649
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	11	$2,896
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,262
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	22	53	$1,091
A4456	Adhesive remover, wipes, any type, each	N	N/R	14	$285

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Samuel M. Ortiz, M.D.?

Tedicare shows public-source Medicare data for Samuel M. Ortiz, M.D. (NPI 1740286681), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel M. Ortiz, M.D. have ACO affiliation data?

Samuel M. Ortiz, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Samuel M. Ortiz, M.D.?

Samuel M. Ortiz, M.D. is linked to CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (billing NPI 1881642239) in the available physician profile data.

Does Samuel M. Ortiz, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.